Evaluation of the Cedia® heroin metabolite (6-AM) immunoassay with urine specimens from a criminal justice drug-testing program

Journal of Analytical Toxicology

Volumn 29, Issue 3, 2005, Pages 201-204

  Jenkins, Amanda J ^a   Lavins, Eric S ^a   Snyder, Ann ^b  

^a Office of the Cuyahoga County Coroner   (United States)

^b Cuyahoga Co Ct of Com Pleas Lab ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEDIA; CODEINE; DIAMORPHINE; DRUG METABOLITE; HYDROCODONE; HYDROMORPHONE; ILLICIT DRUG; MORPHINE; MORPHINE 6 ACETATE; OXYCODONE; PENTAZOCINE; 6-O-MONOACETYLMORPHINE; MORPHINE DERIVATIVE;

CONFERENCE PAPER; CRIMINAL JUSTICE; CROSS REACTION; DEVICE; DRUG DETERMINATION; DRUG IDENTIFICATION; DRUG SCREENING; DRUG URINE LEVEL; ENZYME IMMUNOASSAY; HUMAN; HUMAN CELL; MASS SPECTROMETRY; SAMPLING; TOXICITY TESTING; ARTICLE; CRIMINAL LAW; IMMUNOASSAY; LEGAL ASPECT; MASS FRAGMENTOGRAPHY; METHODOLOGY; SENSITIVITY AND SPECIFICITY; STANDARD; SUBSTANCE ABUSE; URINE;

CRIMINAL LAW; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; IMMUNOASSAY; MORPHINE DERIVATIVES; REFERENCE STANDARDS; SENSITIVITY AND SPECIFICITY; SUBSTANCE ABUSE DETECTION;

EID: 17144412501     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/29.3.201     Document Type: Conference Paper

References (6)

1. A.J. Jenkins and K. Gubanich. Disposition of citalopram in biological specimens from postmortem cases. J. Forensic Sci. 47(1): 159-164 (2002).
2. CEDIA® Heroin Metabolite (6-AM) Assay package insert Microgenics™ Corporation, Fremont, CA. #10306723-0. 2002-11.
3. C. George, S. George, and S. Parmar. Application of the CEDIA 6-MAM assay to routine drugs-of-abuse screening. J. Anal. Toxicol. 26: 233-235 (2002).
4. A.C. Spanbauer, S. Casseday, D. Davoudzadeh, K.L. Preston, and M.A. Huestis. Detection of opiate use in a methadone maintenance treatment population with the CEDIA 6-acetylmorphine and CEDIA DAU opiate assays. J. Anal. Toxicol. 25: 515-519 (2001).
5. A. Scholer, N. Grignaschi, U. Mundinger, W. Strobel, and S. Fry. Evaluation of the Cedia 6-AM test in urine and serum samples. Ther. Drug Monit. 23(4): 491 (2001) [Abstract No. 139, 7th International Congress of TDM-CT].
6. J.H. Lewis and S. Fu. Use of the Cedia 6-acetylmorphine assay as a confirmation technique following GC/MS in medico-legal opiate screening. Ther. Drug Monit. 25(4): 491 (2003) [Abstract No. 19, 8th International Congress of TDM-CT].